Device
Airvo
Airvo is a medical device with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(2)
Detailed Status
Terminated1
Recruiting1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
terminated133%
recruiting133%
withdrawn133%
Recent Activity
Clinical Trials (3)
Showing 3 of 3 trials
NCT05358262Phase 2
High Heated Humidity in Stem Cell Transplant
NCT04576936Not Applicable
AIRVO Device Intervention for Moderate to Severe COPD
NCT02780518Not Applicable
Airvo/Optiflow High Flow Nasal Oxygenation During Microlaryngeal Surgery
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3